1. Frailty and Drug Safety at Older Ages

   • Martin Gulliford

   Commentary 19 January 2019 Pages: 699 - 700

2. Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

   • Lauren Pavlik
   • Arie Regev
   • Naga P. Chalasani

   Review Article 14 February 2019 Pages: 701 - 711

3. Identifying Data Elements to Measure Frailty in a Dutch Nationwide Electronic Medical Record Database for Use in Postmarketing Safety Evaluation: An Exploratory Study

   • Janet Sultana
   • Ingrid Leal
   • Gianluca Trifiro’

   Short Communication 08 January 2019 Pages: 713 - 719

4. A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding

   • Christopher McMaster
   • David Liew
   • Albert Frauman

   Short Communication 06 February 2019 Pages: 721 - 725

   

5. An Implementation and Visualization of the Tree-Based Scan Statistic for Safety Event Monitoring in Longitudinal Electronic Health Data

   • Stephen E. Schachterle
   • Sharon Hurley
   • Andrew Bate

   Short Communication 08 January 2019 Pages: 727 - 741

   

6. A Comparison Study of Algorithms to Detect Drug–Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches

   • Minh Pham
   • Feng Cheng
   • Kandethody Ramachandran

   Original Research Article 14 February 2019 Pages: 743 - 750

   

7. Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

   • Subrata Ghosh
   • Lianne S. Gensler
   • Bruce E. Strober

   Original Research Article Open access 09 February 2019 Pages: 751 - 768

   

8. Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma

   • Mats Carlsson
   • Martin Braddock
   • Gene Colice

   Original Research Article Open access 16 January 2019 Pages: 769 - 784

   

9. All-Cause Mortality Associated with Tramadol Use: A Case-Crossover Study

   • Sohyun Jeong
   • Ha Jin Tchoe
   • Ju-Young Shin

   Original Research Article 10 January 2019 Pages: 785 - 796

   

10. The 10th International Congress on Cutaneous Adverse Drug Reactions, Shimane, Japan, 2018: Focus on New Discoveries

    • Cristina Olteanu
    • Neil H. Shear
    • Roni P. Dodiuk-Gad

    Meeting Report 29 April 2019 Pages: 797 - 801

11. Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends

    • Mark Lebwohl

    Book Review 08 May 2019 Pages: 803 - 803

12. Correction to: vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues

    • Tomas Bergvall
    • G. Niklas Norén
    • Marie Lindquist

    Correction Open access 12 March 2019 Pages: 805 - 805

13. Correction to: A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding

    • Christopher McMaster
    • David Liew
    • Albert Frauman

    Correction 15 April 2019 Pages: 807 - 807

14. Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

    • Subrata Ghosh
    • Lianne S. Gensler
    • Bruce E. Strober

    Correction Open access 22 April 2019 Pages: 809 - 809